Glioblastoma Clinical Trials in Houston, TX

View the best 10 glioblastoma medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Glioblastoma clinical trial.

Trials in Houston, Texas

Here are the top 7 medical studies for glioblastoma in Houston, Texas

GPC-3 CAR T Cells

CAR T-cell Therapy

Recruiting1 awardPhase 1

"This trial will test a new treatment for brain tumors that combines antibodies and T cells. The researchers will genetically modify T cells to recognize and kill cancer cells more effectively. They will also use a drug to

Debio 0123 +2 More

Chemotherapy

Recruiting1 awardPhase 1 & 2

This trial is testing a new drug called Debio 0123 combined with standard treatments for adults with aggressive brain cancer. It aims to find the best dose, ensure safety, and check if it works better than current treatments.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2

This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2

This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2

This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3

This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3

This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.

Popular Filters

Trials With No Placebo

CAR T-cell Therapy

GPC3-CAR T Cells for Brain Cancer

Recruiting1 awardPhase 1

Houston, Texas

"This trial will test a new treatment for brain tumors that combines antibodies and T cells. The researchers will genetically modify T cells to recognize and kill cancer cells more effectively. They will also use a drug to

Monoclonal Antibodies

Ivonescimab for Brain Tumors

Recruiting1 awardPhase 1 & 2

Houston, Texas

"This trial aims to determine the highest safe dose of ivonescimab for patients with recurrent glioblastoma in Phase 1. In Phase 2, researchers will test if this dose can

ALK Inhibitor

Lorlatinib for Brain Tumors

Recruiting1 awardPhase < 1

Houston, Texas

This trial aims to see how well the drug loratinib works in treating children with a specific type of brain tumor called high-grade glioma. The study will also look at the safety of using lor

Alkylating agent

Olutasidenib + Temozolomide for Brain Tumors

Recruiting1 awardPhase 2

Houston, Texas

This trial will test if a drug can extend the life of kids/young adults with a deadly brain tumor linked to a genetic mutation.

Chemotherapy

Ultrasound-Assisted Chemotherapy for Glioblastoma

Recruiting2 awardsPhase 3

Houston, Texas

This trial tests a new method to treat recurrent brain cancer using an ultrasound device called SonoCloud-9. The device helps open the brain's protective barrier so that more of the chemotherapy drug carboplatin can reach the tumor. The goal is to see if this combination makes the treatment more effective. Carboplatin has been used in various studies for treating high-grade gliomas and glioblastomas, often showing modest efficacy due to low tissue concentration when delivered intravenously.

mTOR Inhibitor

Ribociclib + Everolimus for Brain Tumors

Recruiting1 awardPhase 2

Houston, Texas

This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.